News
NaoTrac neurosurgical navigation robot has officially received medical device approval from India’s CDSCO.
Brain Navi Biotechnology announced that its single-use neuroendoscope, KrystoLens, has officially received TFDA certification.
Cottbus, Germany – The first surgeries with the neurosurgical navigation robot NaoTrac have now been successfully started at the Medizinische Universität Lausitz – Carl Thiem.
Brain Navi Biotechnology has officially received U.S. FDA 510(k) clearance for its neurosurgical robot NaoTrac, now classified as a "Stereotaxic Guiding Surgical Device."
News
Brain Navi Biotechnology announced that its single-use neuroendoscope, KrystoLens, has officially received TFDA certification.
NaoTrac neurosurgical navigation robot has officially received medical device approval from India’s CDSCO.
The KrystoLens wins the “Innovative Medical Devices and Diagnostic Technology Award" under the 22nd National Innovation Awards.
Cottbus, Germany – The first surgeries with the neurosurgical navigation robot NaoTrac have now been successfully started at the Medizinische Universität Lausitz – Carl Thiem.
Brain Navi Biotechnology has officially received U.S. FDA 510(k) clearance for its neurosurgical robot NaoTrac, now classified as a "Stereotaxic Guiding Surgical Device."
The article primarily shares the experiences of neurosurgeons in Bolivia, Latin America, regarding their use of NaoTrac and the publication of their findings.
Brain Navi Joined Mayo Clinic ASU Accelerator in March 2024
